Paris, France

Dominique Costantini

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 1.6

ph-index = 3

Forward Citations = 67(Granted Patents)


Company Filing History:


Years Active: 2005-2023

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Dominique Costantini

Introduction

Dominique Costantini is a prominent inventor based in Paris, France. He has made significant contributions to the field of cancer treatment, holding a total of 11 patents. His work focuses on innovative therapies that enhance patient outcomes, particularly for those undergoing immune checkpoint inhibitor treatments.

Latest Patents

Among his latest patents, Costantini has developed a treatment for cancer that involves a composition of CTL peptides. This invention aims to improve the treatment of cancer patients who have previously received immune checkpoint inhibitors. Another notable patent is a method for inducing an early T memory response using short peptides in an anti-tumor vaccine. This therapeutic approach is designed for HLA-A2 positive patients and includes a priming period with multiple administrations of the therapeutic peptide to stimulate a memory T cell response.

Career Highlights

Throughout his career, Costantini has worked with several notable companies in the pharmaceutical and biotechnology sectors. He has been associated with Bioalliance Pharma and Ose Immunotherapeutics, where he has contributed to the development of innovative cancer therapies.

Collaborations

Costantini has collaborated with various professionals in his field, including Caroline Lemarchand and Jean-Marc Aiache. These collaborations have furthered his research and development efforts in cancer treatment.

Conclusion

Dominique Costantini's work exemplifies the impact of innovation in cancer treatment. His patents and collaborations reflect a commitment to advancing therapeutic options for patients. His contributions are vital in the ongoing fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…